SHSE:688073Pharmaceuticals
3 Stocks Estimated At 25% To 48.7% Below Intrinsic Value
As global markets edge towards record highs, driven by a robust performance in U.S. stock indexes and optimism in European and Asian markets, investors are keenly focused on inflation trends and interest rate expectations. In this climate of economic uncertainty, identifying undervalued stocks—those trading below their intrinsic value—can offer potential opportunities for investors looking to capitalize on market fluctuations while maintaining a cautious approach to risk management.